位置:首页 > 蛋白库 > TRPV1_RABIT
TRPV1_RABIT
ID   TRPV1_RABIT             Reviewed;         842 AA.
AC   Q6RX08;
DT   26-APR-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   03-AUG-2022, entry version 115.
DE   RecName: Full=Transient receptor potential cation channel subfamily V member 1;
DE            Short=TrpV1;
DE   AltName: Full=Osm-9-like TRP channel 1;
DE            Short=OTRPC1;
DE   AltName: Full=Vanilloid receptor 1;
GN   Name=Trpv1;
OS   Oryctolagus cuniculus (Rabbit).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Lagomorpha; Leporidae; Oryctolagus.
OX   NCBI_TaxID=9986;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS
RP   OF TYR-514; LEU-550 AND ILE-553.
RX   PubMed=14996838; DOI=10.1074/jbc.m312577200;
RA   Gavva N.R., Klionsky L., Qu Y., Shi L., Tamir R., Edenson S., Zhang T.J.,
RA   Viswanadhan V.N., Toth A., Pearce L.V., Vanderah T.W., Porreca F.,
RA   Blumberg P.M., Lile J., Sun Y., Wild K., Louis J.C., Treanor J.J.;
RT   "Molecular determinants of vanilloid sensitivity in TRPV1.";
RL   J. Biol. Chem. 279:20283-20295(2004).
RN   [2]
RP   FUNCTION, SUBCELLULAR LOCATION, AND MUTAGENESIS OF ASP-650.
RX   PubMed=11035011; DOI=10.1074/jbc.m006184200;
RA   Nilius B., Vennekens R., Prenen J., Hoenderop J.G., Droogmans G.,
RA   Bindels R.J.M.;
RT   "The single pore residue Asp542 determines Ca2+ permeation and Mg2+ block
RT   of the epithelial Ca2+ channel.";
RL   J. Biol. Chem. 276:1020-1025(2001).
CC   -!- FUNCTION: Ligand-activated non-selective calcium permeant cation
CC       channel involved in detection of noxious chemical and thermal stimuli
CC       (PubMed:14996838, PubMed:11035011). Seems to mediate proton influx and
CC       may be involved in intracellular acidosis in nociceptive neurons.
CC       Involved in mediation of inflammatory pain and hyperalgesia. Sensitized
CC       by a phosphatidylinositol second messenger system activated by receptor
CC       tyrosine kinases, which involves PKC isozymes and PCL. Can be activated
CC       by endogenous compounds, including 12-hydroperoxytetraenoic acid and
CC       bradykinin. Acts as ionotropic endocannabinoid receptor with central
CC       neuromodulatory effects. Triggers a form of long-term depression
CC       (TRPV1-LTD) mediated by the endocannabinoid anandamine in the
CC       hippocampus and nucleus accumbens by affecting AMPA receptors
CC       endocytosis (By similarity). Activation by vanilloids, like capsaicin,
CC       and temperatures higher than 42 degrees Celsius, exhibits a time- and
CC       Ca(2+)-dependent outward rectification, followed by a long-lasting
CC       refractory state. Mild extracellular acidic pH (6.5) potentiates
CC       channel activation by noxious heat and vanilloids, whereas acidic
CC       conditions (pH <6) directly activate the channel (By similarity).
CC       {ECO:0000250|UniProtKB:O35433, ECO:0000269|PubMed:11035011,
CC       ECO:0000269|PubMed:14996838}.
CC   -!- ACTIVITY REGULATION: The channel is sensitized by ATP binding. Repeated
CC       stimulation with capsaicin gives rise to progressively smaller
CC       responses, due to desensitization. This desensitization is triggered by
CC       the influx of calcium ions and is inhibited by elevated ATP levels.
CC       Ca(2+) and CALM displace ATP from its binding site and trigger a
CC       conformation change that leads to a closed, desensitized channel. The
CC       double-knot toxin (DkTx) from the Chinese earth tiger tarantula
CC       activates the channel and traps it in an open conformation (By
CC       similarity). The Scolopendra mutilans RhTx toxin potentiates the heat
CC       activation pathway mediated by this channel by binding to the charge-
CC       rich outer pore region (in an activated state) (By similarity). Channel
CC       activity is activated via the interaction with PIRT and
CC       phosphatidylinositol 4,5-bisphosphate (PIP2). Both PIRT and PIP2 are
CC       required to activate channel activity. Intracellular PIP2 inhibits
CC       desensitization (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:Q704Y3}.
CC   -!- SUBUNIT: Interacts with PIRT (By similarity). Homotetramer. May also
CC       form a heteromeric channel with TRPV3. Interacts with CALM, PRKCM and
CC       CSK. Interacts with PRKCG and NTRK1, probably by forming a trimeric
CC       complex (By similarity). Interacts with the Scolopendra mutilans RhTx
CC       toxin (By similarity). Interacts with TMEM100 (By similarity).
CC       Interacts with PACS2 (By similarity). {ECO:0000250,
CC       ECO:0000250|UniProtKB:O35433, ECO:0000250|UniProtKB:Q704Y3,
CC       ECO:0000250|UniProtKB:Q8NER1}.
CC   -!- SUBCELLULAR LOCATION: Postsynaptic cell membrane
CC       {ECO:0000250|UniProtKB:O35433}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:O35433}. Cell projection, dendritic spine
CC       membrane {ECO:0000250|UniProtKB:O35433}; Multi-pass membrane protein
CC       {ECO:0000250|UniProtKB:O35433}. Cell membrane
CC       {ECO:0000269|PubMed:11035011, ECO:0000269|PubMed:14996838}; Multi-pass
CC       membrane protein {ECO:0000250|UniProtKB:O35433}. Note=Mostly, but not
CC       exclusively expressed in postsynaptic dendritic spines.
CC       {ECO:0000250|UniProtKB:O35433}.
CC   -!- DOMAIN: The association domain (AD) is necessary for self-association.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylation by PKA reverses capsaicin-induced
CC       dephosphorylation at multiple sites. Phosphorylation by CAMKII seems to
CC       regulate binding to vanilloids. Phosphorylated and modulated by PRKCE,
CC       PRKCM and probably PRKCZ. Dephosphorylation by calcineurin seems to
CC       lead to receptor desensitization and phosphorylation by CAMKII recovers
CC       activity. {ECO:0000250|UniProtKB:O35433}.
CC   -!- SIMILARITY: Belongs to the transient receptor (TC 1.A.4) family. TrpV
CC       subfamily. TRPV1 sub-subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY487342; AAR34458.1; -; mRNA.
DR   RefSeq; NP_001075635.1; NM_001082166.1.
DR   STRING; 9986.ENSOCUP00000010529; -.
DR   GeneID; 100008926; -.
DR   KEGG; ocu:100008926; -.
DR   CTD; 7442; -.
DR   eggNOG; KOG3676; Eukaryota.
DR   InParanoid; Q6RX08; -.
DR   OrthoDB; 693004at2759; -.
DR   Proteomes; UP000001811; Unplaced.
DR   GO; GO:0070161; C:anchoring junction; IEA:UniProtKB-KW.
DR   GO; GO:0032591; C:dendritic spine membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; ISS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0015278; F:calcium-release channel activity; ISS:UniProtKB.
DR   GO; GO:0005516; F:calmodulin binding; ISS:UniProtKB.
DR   GO; GO:0005231; F:excitatory extracellular ligand-gated ion channel activity; ISS:UniProtKB.
DR   GO; GO:0005230; F:extracellular ligand-gated ion channel activity; ISS:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0035091; F:phosphatidylinositol binding; ISS:UniProtKB.
DR   GO; GO:0004888; F:transmembrane signaling receptor activity; ISS:UniProtKB.
DR   GO; GO:0098703; P:calcium ion import across plasma membrane; ISS:UniProtKB.
DR   GO; GO:0070588; P:calcium ion transmembrane transport; ISS:UniProtKB.
DR   GO; GO:0071468; P:cellular response to acidic pH; ISS:UniProtKB.
DR   GO; GO:0071312; P:cellular response to alkaloid; ISS:UniProtKB.
DR   GO; GO:0071318; P:cellular response to ATP; ISS:UniProtKB.
DR   GO; GO:0034605; P:cellular response to heat; ISS:UniProtKB.
DR   GO; GO:0051289; P:protein homotetramerization; ISS:UniProtKB.
DR   GO; GO:1901594; P:response to capsazepine; ISS:UniProtKB.
DR   Gene3D; 1.25.40.20; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR005821; Ion_trans_dom.
DR   InterPro; IPR024862; TRPV.
DR   InterPro; IPR024863; TRPV1.
DR   InterPro; IPR008347; TrpV1-4.
DR   PANTHER; PTHR10582; PTHR10582; 1.
DR   PANTHER; PTHR10582:SF17; PTHR10582:SF17; 1.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF00520; Ion_trans; 1.
DR   PRINTS; PR01768; TRPVRECEPTOR.
DR   SMART; SM00248; ANK; 4.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
PE   1: Evidence at protein level;
KW   ANK repeat; ATP-binding; Calcium; Calcium channel; Calcium transport;
KW   Calmodulin-binding; Cell membrane; Cell projection; Glycoprotein;
KW   Ion channel; Ion transport; Membrane; Metal-binding; Nucleotide-binding;
KW   Phosphoprotein; Postsynaptic cell membrane; Reference proteome; Repeat;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..842
FT                   /note="Transient receptor potential cation channel
FT                   subfamily V member 1"
FT                   /id="PRO_0000215340"
FT   TOPO_DOM        1..435
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        436..456
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        457..474
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        475..500
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        501..513
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        514..534
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        535..538
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        539..559
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        560..574
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        575..602
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        603..661
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TRANSMEM        662..690
FT                   /note="Helical"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   TOPO_DOM        691..842
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   REPEAT          113..155
FT                   /note="ANK 1"
FT   REPEAT          156..202
FT                   /note="ANK 2"
FT   REPEAT          203..249
FT                   /note="ANK 3"
FT   REPEAT          250..285
FT                   /note="ANK 4"
FT   REPEAT          286..334
FT                   /note="ANK 5"
FT   REPEAT          335..361
FT                   /note="ANK 6"
FT   REGION          1..64
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          688..716
FT                   /note="AD"
FT                   /evidence="ECO:0000250"
FT   REGION          771..805
FT                   /note="Interaction with calmodulin"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   REGION          781..796
FT                   /note="Required for PIP2-mediated channel inhibition"
FT   MOTIF           647..650
FT                   /note="Selectivity filter"
FT                   /evidence="ECO:0000305|PubMed:11035011"
FT   BINDING         118
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   BINDING         158
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   BINDING         163
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   BINDING         167
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   BINDING         202..205
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   BINDING         213..214
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   BINDING         514..515
FT                   /ligand="resiniferatoxin"
FT                   /ligand_id="ChEBI:CHEBI:8809"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   BINDING         560
FT                   /ligand="resiniferatoxin"
FT                   /ligand_id="ChEBI:CHEBI:8809"
FT                   /ligand_note="agonist"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   BINDING         650
FT                   /ligand="Ca(2+)"
FT                   /ligand_id="ChEBI:CHEBI:29108"
FT                   /ligand_note="ligand shared between two neighboring
FT                   subunits"
FT                   /evidence="ECO:0000250|UniProtKB:Q9R186"
FT   MOD_RES         147
FT                   /note="Phosphothreonine; by PKA; in vitro"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   MOD_RES         373
FT                   /note="Phosphothreonine; by PKA; in vitro"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   MOD_RES         505
FT                   /note="Phosphoserine; by PKC/PRKCE"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   MOD_RES         708
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   MOD_RES         778
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   MOD_RES         804
FT                   /note="Phosphoserine; by PKC/PRKCE and PKC/PRKCZ"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   MOD_RES         824
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35433"
FT   CARBOHYD        607
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         514
FT                   /note="Y->A: Reduces sensitivity to capsaicin more than
FT                   100-fold; when associated with T-553."
FT                   /evidence="ECO:0000269|PubMed:14996838"
FT   MUTAGEN         550
FT                   /note="L->M: Confers sensitivity to capsaicin,
FT                   resiniferatoxin and other vanilloids and confers binding to
FT                   resiniferatoxin; when associated with T-553."
FT                   /evidence="ECO:0000269|PubMed:14996838"
FT   MUTAGEN         553
FT                   /note="I->T: Confers sensitivity to capsaicin,
FT                   resiniferatoxin and other vanilloids and confers binding to
FT                   resiniferatoxin; when associated with M-550. Reduces
FT                   sensitivity to capsaicin more than 100-fold; when
FT                   associated with A-514."
FT                   /evidence="ECO:0000269|PubMed:14996838"
FT   MUTAGEN         650
FT                   /note="D->A: Abolishes calcium permeability."
FT                   /evidence="ECO:0000269|PubMed:11035011"
FT   MUTAGEN         650
FT                   /note="D->E,N,M: Attenuates calcium permeability."
FT                   /evidence="ECO:0000269|PubMed:11035011"
FT   MUTAGEN         650
FT                   /note="D->K: Abolishes channel activity."
FT                   /evidence="ECO:0000269|PubMed:11035011"
SQ   SEQUENCE   842 AA;  95003 MW;  D9D6F755E8A8CDA7 CRC64;
     MKRWVSLDSG ESEDPLPEDT CPDLLDGDSN AKPPPAKPHI FSTAKSRSRL FGKGDSEETS
     PMDCSYEEGE LAPCPAITVS SVIIVQRSGD GPTCARQLSQ DSVAAAGAEK PLKLYDRRRI
     FEAVAQNNCQ ELESLLCFLQ RSKKRLTDSE FKDPETGKTC LLKAMLNLHS GQNDTIPLLL
     EIARQTDSLK EFVNASYTDS YYKGQTALHI AIERRNMALV TLLVENGADV QAAANGDFFK
     KTKGRPGFYF GELPLSLAAC TNQLAIVKFL LQNSWQPADI SARDSVGNTV LHALVEVADN
     TPDNTKFVTS MYNEILILGA KLHPTLKLEE LINKKGLTPL ALAAGSGKIG VLAYILQREI
     LEPECRHLSR KFTEWAYGPV HSSLYDLSCI DTCERNSVLE VIAYSSSETP NRHDMLLVEP
     LNRLLQDKWD RVVKRIFYFN FFVYCLYMII FTTAAYYRPV DGLPPYKLRN LPGDYFRVTG
     EILSVAGGVY FFFRGIQYFL QRRPSMKALF VDSYSEMLFF VQALFMLATV VLYFSHCKEY
     VATMVFSLAL GWINMLYYTR GFQQMGIYAV MIEKMILRDL CRFMFVYLVF LFGFSTAVVT
     LIEDGKNSST SAESTSHRWR GFGCRSSDSS YNSLYSTCLE LFKFTIGMGD LEFTENYDFK
     AVFIILLLAY VILTYILLLN MLIALMGETV NKIAQESKSI WKLQRAITIL DTEKGFLKCM
     RKAFRSGKLL QVGYTPDGKD DCRWCFRVDE VNWTTWNTNV GIINEDPGNC EGVKRTLSFS
     LRSGRVSGRN WKNFALVPLL RDASTRDRHP XPPEDVHLRP FVGSLKPGDA ELFKDSVAAA
     EK
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2025